BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12665679)

  • 1. Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy.
    Avilés A; Neri N; Fernández R; Calva A; Huerta-Guzmán J; Nambo MJ
    Med Oncol; 2003; 20(1):13-7. PubMed ID: 12665679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
    Avilés A; Cleto S; Castañeda C; Nambo MJ
    Hematology; 2007 Jun; 12(3):241-4. PubMed ID: 17558700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma.
    Hu Y; Chen M; Song Y; Liu X; Gou F; Zhang J; Huang Y
    Am J Clin Oncol; 2020 Apr; 43(4):257-262. PubMed ID: 31764026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
    Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
    Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemotherapy and external beam radiation for stage IE and IIE natural killer T-cell lymphoma of nasal cavity.
    Wang B; Lu JJ; Ma X; Guo Y; Lu H; Hong X; Li J
    Leuk Lymphoma; 2007 Feb; 48(2):396-402. PubMed ID: 17325902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
    Vitolo U; Cortellazzo S; Liberati AM; Freilone R; Falda M; Bertini M; Botto B; Cinieri S; Levis A; Locatelli F; Lovisone E; Marmont F; Pizzuti M; Rossi A; Viero P; Barbui T; Grignani F; Resegotti L
    J Clin Oncol; 1997 Feb; 15(2):491-8. PubMed ID: 9053470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?
    Kim WS; Song SY; Ahn YC; Ko YH; Baek CH; Kim DY; Yoon SS; Lee HG; Kang WK; Lee HJ; Park CH; Park K
    Ann Oncol; 2001 Mar; 12(3):349-52. PubMed ID: 11332147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concurrent chemoradiotherapy for localized nasal NK/T-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2010 Jul; 51(7):500-7. PubMed ID: 20693769
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study.
    Kim SJ; Kim K; Kim BS; Kim CY; Suh C; Huh J; Lee SW; Kim JS; Cho J; Lee GW; Kang KM; Eom HS; Pyo HR; Ahn YC; Ko YH; Kim WS
    J Clin Oncol; 2009 Dec; 27(35):6027-32. PubMed ID: 19884539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective phase II study of L-asparaginase- CHOP plus radiation in newly diagnosed extranodal NK/T-cell lymphoma, nasal type.
    Lin N; Song Y; Zheng W; Tu M; Xie Y; Wang X; Ping L; Ying Z; Zhang C; Deng L; Liu W; Zhu J
    J Hematol Oncol; 2013 Jul; 6():44. PubMed ID: 23816178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
    Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
    Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
    Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
    J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
    Lee KW; Yun T; Kim DW; Im SA; Kim TY; Yoon SS; Heo DS; Bang YJ; Park S; Kim BK; Kim NK
    Leuk Lymphoma; 2006 Jul; 47(7):1274-82. PubMed ID: 16923557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case series of localized nasal NK/T-cell lymphoma treated with preceding intensified local radiation therapy before systemic chemotherapy].
    Tamai Y; Imataki O; Abe Y; Hagiwara S; Ito I; Asakura H; Harada H; Kamata M; Nishimura T; Kawakami K
    Gan To Kagaku Ryoho; 2006 May; 33(5):687-90. PubMed ID: 16685174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective high-dose chemotherapy combined with CD34+-selected peripheral blood stem cell transplantation in a patient with cutaneous involvement of nasal NK/T-cell lymphoma.
    Koizumi K; Fujimoto K; Haseyama Y; Endo T; Nishio M; Yokota K; Itoh T; Sawada K; Koike T
    Eur J Haematol; 2004 Feb; 72(2):140-4. PubMed ID: 14962252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma.
    Avilés A; Guzmán R; Delgado S; Nambo MJ; García EL; Díaz-Maqueo JC
    Am J Hematol; 1996 Aug; 52(4):275-80. PubMed ID: 8701945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the appendix in a relapsed case of primary nasal NK/T-cell lymphoma.
    Tsujimura H; Takagi T; Tamaru J; Sakai C
    Leuk Lymphoma; 2000 May; 37(5-6):633-4. PubMed ID: 11042526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.